Pharmacy News and Stories

The CU Skaggs School of Pharmacy and Pharmaceutical Sciences is thrilled to introduce Blake Hill, PhD, as Chair of the Department of Pharmaceutical Sciences (DOPS). Dr. Hill’s passion for making a difference in health, coupled with an eagerness to face the challenges posed by environmental and climate-induced changes, will propel the Department of Pharmaceutical Sciences to new heights at CU Pharmacy.

Brad Bobel | March 25, 2024

Krishna Mallela, PhD, and his team received press coverage for the lab’s work on SARS-CoV-2 variants, which focused on the study which highlights the importance of positive and negative selection in evolution of SARS-CoV-2 variants.

NewsMedical | December 28, 2021

Both Pfizer’s Paxlovid and Merck’s molnupiravir are cleared for emergency use in non-hospitalized people who have mild-to-moderate symptoms and are at heightened risk of developing severe disease. Peter Anderson, PharmD spoke with Health regarding their effectiveness.

Health.com | December 28, 2021

Peter Anderson, PharmD spoke with the Guardian about Paxlovid and molnupiravir, which were authorized by the FDA recently. Supplies of Paxlovid are limited while molnupiravir is less effective than hoped, but they are a very important step forward.

The Guardian | December 28, 2021

A cutting-edge robot that will cut screening time for new drugs in half to get more effective therapies to people and animals is busy doing lifesaving work. Professor Dan LaBarbera, PhD is the founding director of the Center for Drug Discovery at CU Anschutz.

Denver 7 | October 19, 2021